These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8324151)

  • 21. In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria.
    Wexler HM; Molitoris E; Molitoris D; Finegold SM
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2232-5. PubMed ID: 8878617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative activities of eight quinolones against members of the Bacteroides fragilis group.
    Borobio MV; Conejo M; Ramirez E; Suarez AI; Perea EJ
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1442-5. PubMed ID: 8092852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes.
    Spangler SK; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2471-6. PubMed ID: 7840591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activities of gemifloxacin (SB 265805, LB20304) compared to those of other oral antimicrobial agents against unusual anaerobes.
    Goldstein EJ; Citron DM; Vreni Merriam C; Tyrrell K; Warren Y
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2726-30. PubMed ID: 10543754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of meropenem compared with imipenem, metronidazole, ampicillin, and ampicillin/sulbactam against anaerobes.
    Schumacher U; Manncke B; Gerbracht K; Werner H
    Arzneimittelforschung; 1994 Jul; 44(7):859-62. PubMed ID: 7945523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-vitro activity of clinafloxacin (CI-960) and PD 131628-2 against anaerobic bacteria.
    Wexler HM; Molitoris E; Reeves D; Finegold SM
    J Antimicrob Chemother; 1994 Oct; 34(4):579-84. PubMed ID: 7868409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative in vitro activities of trovafloxacin (CP 99,219) and other antimicrobials against clinically significant anaerobes.
    Aldridge KE; Ashcraft D; Bowman KA
    Antimicrob Agents Chemother; 1997 Feb; 41(2):484-7. PubMed ID: 9021215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999-2003.
    Roberts SA; Shore KP; Paviour SD; Holland D; Morris AJ
    J Antimicrob Chemother; 2006 May; 57(5):992-8. PubMed ID: 16507560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of the new quinolone BAY y 3118 against anaerobic bacteria.
    Nord CE; Lindmark A; Persson I
    Eur J Clin Microbiol Infect Dis; 1993 Aug; 12(8):640-2. PubMed ID: 8223667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in the susceptibility of commonly encountered clinically significant anaerobes and susceptibilities of blood isolates of anaerobes to 16 antimicrobial agents, including fidaxomicin and rifaximin, 2008-2012, northern Taiwan.
    Wang FD; Liao CH; Lin YT; Sheng WH; Hsueh PR
    Eur J Clin Microbiol Infect Dis; 2014 Nov; 33(11):2041-52. PubMed ID: 24930042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sensitivity of obligate anaerobes to ofloxacin, pefloxacin, enoxacin and norfloxacin].
    Dubreuil L; Devos J; Romond C; Bryskier A
    Pathol Biol (Paris); 1985 May; 33(5):421-5. PubMed ID: 3162143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative in vitro activity of BAY 12-8039 and five other antimicrobial agents against anaerobic bacteria.
    Edlund C; Sabouri S; Nord CE
    Eur J Clin Microbiol Infect Dis; 1998 Mar; 17(3):193-5. PubMed ID: 9665302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quinolone activity against anaerobes.
    Appelbaum PC
    Drugs; 1999; 58 Suppl 2():60-4. PubMed ID: 10553708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-vitro activity of WIN 57273 compared to the activity of other fluoroquinolones and two beta-lactam antibiotics.
    Chin NX; Neu HC
    J Antimicrob Chemother; 1991 Jun; 27(6):781-91. PubMed ID: 1657856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative in vitro activities of azithromycin, Bay y 3118, levofloxacin, sparfloxacin, and 11 other oral antimicrobial agents against 194 aerobic and anaerobic bite wound isolates.
    Goldstein EJ; Nesbit CA; Citron DM
    Antimicrob Agents Chemother; 1995 May; 39(5):1097-100. PubMed ID: 7625795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of grepafloxacin (OPC-17116) against anaerobic bacteria.
    Wexler HM; Molitoris E; Finegold SM
    Diagn Microbiol Infect Dis; 1994 Jun; 19(2):129-33. PubMed ID: 7805357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of BAY y 3118, and nine other antimicrobial agents against anaerobic bacteria.
    García-Rodríguez JA; García-Sánchez JE; Trujillano-Martín I; García-Sánchez E; García-García MI; Fresnadillo-Martínez MJ
    J Chemother; 1995 Jun; 7(3):189-96. PubMed ID: 7562012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative antimycobacterial activities of difloxacin, temafloxacin, enoxacin, pefloxacin, reference fluoroquinolones, and a new macrolide, clarithromycin.
    Gorzynski EA; Gutman SI; Allen W
    Antimicrob Agents Chemother; 1989 Apr; 33(4):591-2. PubMed ID: 2524998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibilities of bovine summer mastitis bacteria to antimicrobial agents.
    Jousimies-Somer H; Pyörälä S; Kanervo A
    Antimicrob Agents Chemother; 1996 Jan; 40(1):157-60. PubMed ID: 8787898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The comparative activity of twelve 4-quinolone antimicrobials against gram-positive and gram-negative anaerobes.
    Robbins MJ; O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(7):431-4. PubMed ID: 3836865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.